Cellebrite
CLBT
221 hedge funds and large institutions have $1.74B invested in Cellebrite in 2026 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 91 increasing their positions, 53 reducing their positions, and 33 closing their positions.
72% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 53
52% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 33
29% more call options, than puts
Call options by funds: $9.28M | Put options by funds: $7.2M
20% more funds holding in top 10
Funds holding in top 10: 10 → 12 (+2)
6% more funds holding
Funds holding: 209 → 221 (+12)
3.19% less ownership
Funds ownership: 53.95% → 50.76% (-3.2%)
25% less capital invested
Capital invested by funds: $2.33B → $1.74B (-$584M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$40.7M |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$27.8M |
| 3 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$25.2M |
| 4 |
VC
Voss Capital
Houston,
Texas
|
+$24.5M |
| 5 |
P3I
Progeny 3 Inc
Kirkland,
Washington
|
+$17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$78.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$71.5M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$43.4M |
| 4 |
CCPM
Cooper Creek Partners Management
New York
|
-$43.2M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$33.1M |
CLBT Hedge Fund Activity: Q1 2026 in Review
221 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q1 2026, worth a combined $1.74B — down 25% from $2.33B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new CLBT positions and 33 closed out — a net gain of 17 holders — while 91 added to existing stakes and 53 trimmed.
The largest buyer was Brown Capital Management, opening a new position worth an estimated $40.7M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $78.4M.
- 221 institutional investors held Cellebrite (CLBT) as of Q1 2026, up from 209 in Q4 2025.
- Funds reported $1.74B of Cellebrite stock for Q1 2026, down 25% quarter-over-quarter.
- 50 funds opened new Cellebrite positions in Q1 2026 and 33 closed out, a net change of +17 holders.
- The largest Cellebrite buyer in Q1 2026 was Brown Capital Management, an estimated $40.7M added.
- The largest Cellebrite seller in Q1 2026 was T. Rowe Price Investment Management, an estimated $78.4M sold.
Based on aggregated 13F filings for Q1 2026.